search
Back to results

Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting (Loop-NVPO)

Primary Purpose

Postoperative Nausea and Vomiting

Status
Completed
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
Dexamethasone and Ondansetron
Placebo
Sponsored by
Hopital Foch
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Postoperative Nausea and Vomiting focused on measuring Anesthesiology, Complications, Closed-loop

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients aged 18-75 years
  • Scheduled for bariatric surgery under total intra-venous closed-loop anesthesia
  • Apfel score equal or greater than 2
  • Consenting to participate in the study

Exclusion Criteria:

  • Pregnant, breast feeding women
  • Allergy
  • Contraindication to dexamethasone
  • Contraindication to ondansetron
  • Contraindication to propofol, remifentanil, morphine, ketoprofen
  • Limit to the use of bispectral index

Sites / Locations

  • Clinique de la Baie des Citrons

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Dexamethasone and Ondansetron

Placebo

Arm Description

Each patient will receive Dexamethasone and Ondansetron

Each patient will receive placebo instead of Dexamethasone and Ondansetron

Outcomes

Primary Outcome Measures

Postoperative nausea or vomiting
Severe nausea (> to 4 on a 0-10 visual analogue scale) or vomiting

Secondary Outcome Measures

incidence of nausea
incidence of nausea with delay of occurrence and severity (0-10 visual analogue scale)
incidence of vomiting
incidence of vomiting with delay of occurrence
rescue treatment
use of rescue treatment for PONV
pain
postoperative pain score (0-10 visual analogue scale)
sedation
postoperative sedation (0-10 visual analogue scale)

Full Information

First Posted
May 29, 2013
Last Updated
October 28, 2016
Sponsor
Hopital Foch
search

1. Study Identification

Unique Protocol Identification Number
NCT01876290
Brief Title
Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting
Acronym
Loop-NVPO
Official Title
Should we Associate Dexamethasone and Ondansetron to Closed-loop Anesthesia to Reduce the Incidence of Postoperative Nausea and Vomiting After Bariatric Surgery?
Study Type
Interventional

2. Study Status

Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
May 2013 (undefined)
Primary Completion Date
January 2014 (Actual)
Study Completion Date
March 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hopital Foch

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigators want to test if it is indicated to associate dexamethasone and ondansetron in obese patients having bariatric surgery under total intra-venous closed-loop anesthesia.
Detailed Description
Obese patients having bariatric surgery have frequently postoperative nausea and vomiting (PONV). We want to test if it is indicated to associate dexamethasone and ondansetron in obese patients having bariatric surgery under total intra-venous closed-loop anesthesia. Two groups to be studied: one will receive 4 mg dexamethasone at the end of the anesthetic induction and 4 mg ondansetron at the end of the surgical procedure, one will receive normal saline. One hundred twenty consecutive patients meeting the inclusion and exclusion criteria and who give written informed consent to participate in the study will be randomly assigned to one of two experimental groups using a 1:1 ratio. Patients will be continuously monitored in the post anesthesia care unit (PACU) and the medical floor for a total of 24 hours post operatively. Episodes of nausea, vomiting and administration of rescue therapy for either nausea or vomiting will be recorded and time stamped. In addition, severity of nausea will be evaluated by the patient using a standard verbal response scale (VRS) ranging from 0-10, 0 being no nausea and 10 being severe nausea. Rescue therapy for PONV episodes will consist of 4 mg ondansetron followed by 0.625 mg droperidol if necessary.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Nausea and Vomiting
Keywords
Anesthesiology, Complications, Closed-loop

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
122 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dexamethasone and Ondansetron
Arm Type
Experimental
Arm Description
Each patient will receive Dexamethasone and Ondansetron
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Each patient will receive placebo instead of Dexamethasone and Ondansetron
Intervention Type
Drug
Intervention Name(s)
Dexamethasone and Ondansetron
Intervention Description
Comparison between Dexamethasone and Ondansetron and placebo in the prevention of postoperative Nausea and Vomiting
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Placebo
Primary Outcome Measure Information:
Title
Postoperative nausea or vomiting
Description
Severe nausea (> to 4 on a 0-10 visual analogue scale) or vomiting
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
incidence of nausea
Description
incidence of nausea with delay of occurrence and severity (0-10 visual analogue scale)
Time Frame
one day after anesthesia
Title
incidence of vomiting
Description
incidence of vomiting with delay of occurrence
Time Frame
one day after anesthesia
Title
rescue treatment
Description
use of rescue treatment for PONV
Time Frame
one day after anesthesia
Title
pain
Description
postoperative pain score (0-10 visual analogue scale)
Time Frame
one day after anesthesia
Title
sedation
Description
postoperative sedation (0-10 visual analogue scale)
Time Frame
one day after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients aged 18-75 years Scheduled for bariatric surgery under total intra-venous closed-loop anesthesia Apfel score equal or greater than 2 Consenting to participate in the study Exclusion Criteria: Pregnant, breast feeding women Allergy Contraindication to dexamethasone Contraindication to ondansetron Contraindication to propofol, remifentanil, morphine, ketoprofen Limit to the use of bispectral index
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marc Fischler, MD
Organizational Affiliation
Hôpital Foch
Official's Role
Study Chair
Facility Information:
Facility Name
Clinique de la Baie des Citrons
City
Nouméa
ZIP/Postal Code
98800
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
21233500
Citation
Liu N, Chazot T, Hamada S, Landais A, Boichut N, Dussaussoy C, Trillat B, Beydon L, Samain E, Sessler DI, Fischler M. Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth Analg. 2011 Mar;112(3):546-57. doi: 10.1213/ANE.0b013e318205680b. Epub 2011 Jan 13.
Results Reference
background
PubMed Identifier
21401538
Citation
Song JW, Park EY, Lee JG, Park YS, Kang BC, Shim YH. The effect of combining dexamethasone with ondansetron for nausea and vomiting associated with fentanyl-based intravenous patient-controlled analgesia. Anaesthesia. 2011 Apr;66(4):263-7. doi: 10.1111/j.1365-2044.2011.06648.x.
Results Reference
background
PubMed Identifier
26866433
Citation
Bataille A, Letourneulx JF, Charmeau A, Lemedioni P, Leger P, Chazot T, Le Guen M, Diemunsch P, Fischler M, Liu N. Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: A randomised double-blind placebo-controlled study. Eur J Anaesthesiol. 2016 Dec;33(12):898-905. doi: 10.1097/EJA.0000000000000427.
Results Reference
derived

Learn more about this trial

Dexamethasone and Ondansetron Versus Placebo for Postoperative Nausea and Vomiting

We'll reach out to this number within 24 hrs